BioJapan 2026
BioJapan marks its 40th anniversary with a combined exhibition, seminar and partnering programme covering biotechnology, regenerative medicine and digital health.
Visit official website
What you need to know
BioJapan 2026 runs from 7–9 October, 10:00–17:00, at Pacifico Yokohama. The 40th-anniversary edition combines a trade exhibition, expert seminars and a business-partnering system. It is held alongside Regenerative Medicine JAPAN and healthTECH JAPAN, broadening the programme from drug discovery and biomanufacturing to cell therapies, diagnostics and digital medicine.
The organiser says the event's partnering platform supports collaboration and both in- and out-licensing of assets. Exhibition themes extend beyond pharmaceuticals to agriculture, food, industrial biotechnology, biomaterials, bioenergy and environmental applications. The parallel health-technology show adds AI-assisted drug discovery, genomics, digital biomarkers, remote monitoring and digital therapeutics.
What to expect
- Drug discovery, biologics and advanced manufacturing
- Regenerative medicine, cell therapy and gene technology
- AI, digital biomarkers and digital therapeutics
- Biotechnology licensing and international partnering
Who should attend
- Biotechnology and pharmaceutical companies
- Researchers, universities and technology-transfer teams
- Health-technology and medical-device startups
- Investors, patent specialists and licensing executives
BioJapan connects scientific discovery with commercialisation through scheduled partnering, licensing conversations and technical programmes. Its co-location with Regenerative Medicine JAPAN and healthTECH JAPAN creates a useful view of how cell therapies, AI-enabled discovery and medical technologies are moving toward market.